Gene therapy approaches for inherited and acquired lung diseases - PubMed
Review
Gene therapy approaches for inherited and acquired lung diseases
D T Curiel et al. Am J Respir Cell Mol Biol. 1996 Jan.
Abstract
Gene therapy is the treatment of any disorder or pathophysiologic state based upon the transfer of genetic information. The lung represents a major target of gene therapy for the treatment of genetic disorders such as cystic fibrosis and alpha 1-antitrypsin deficiency. Other diseases are also being targeted, including pulmonary inflammation, surfactant deficiency, pulmonary hypertension, lung cancer, and malignant mesothelioma. This review will examine some general concepts regarding gene transfer and gene therapy, provide an overview of the current vectors being developed to achieve safe and efficient gene transfer, and summarize the ongoing work to apply this new technology to the treatment of both inherited and acquired pulmonary diseases. Although tremendous progress has been made in the ability to successfully transfer genes to cells, there are several unresolved problems limiting the clinical application of this technology to human pulmonary disease. However, as vector technology evolves, gene therapy may become a reality for a number of lung diseases.
Similar articles
-
Gene therapy for lung disease: hype or hope?
Albelda SM, Wiewrodt R, Zuckerman JB. Albelda SM, et al. Ann Intern Med. 2000 Apr 18;132(8):649-60. doi: 10.7326/0003-4819-132-8-200004180-00008. Ann Intern Med. 2000. PMID: 10766684 Review.
-
[Gene transfer to airway epithelial cells: current status and future direction].
Setoguchi Y, Noto K, Iwakami S, Tajima M, Kira S. Setoguchi Y, et al. Nihon Kyobu Shikkan Gakkai Zasshi. 1994 Dec;32 Suppl:86-95. Nihon Kyobu Shikkan Gakkai Zasshi. 1994. PMID: 7602850 Review. Japanese.
-
Gene therapy for pulmonary diseases.
Kolb M, Martin G, Medina M, Ask K, Gauldie J. Kolb M, et al. Chest. 2006 Sep;130(3):879-84. doi: 10.1378/chest.130.3.879. Chest. 2006. PMID: 16963689 Review.
-
Vectors for pulmonary gene therapy.
Geiger J, Aneja MK, Rudolph C. Geiger J, et al. Int J Pharm. 2010 May 5;390(1):84-8. doi: 10.1016/j.ijpharm.2009.10.010. Epub 2009 Oct 13. Int J Pharm. 2010. PMID: 19825403 Review.
-
Gene therapy for inherited lung disorders: an insight into pulmonary defence.
Vadolas J, Williamson R, Ioannou PA. Vadolas J, et al. Pulm Pharmacol Ther. 2002;15(1):61-72. doi: 10.1006/pupt.2001.0316. Pulm Pharmacol Ther. 2002. PMID: 11969364 Review.
Cited by
-
Recognition and management of pulmonary hypertension.
Wanstall JC, Jeffery TK. Wanstall JC, et al. Drugs. 1998 Dec;56(6):989-1007. doi: 10.2165/00003495-199856060-00004. Drugs. 1998. PMID: 9878988 Review.
-
Zhou MY, Lo SK, Bergenfeldt M, Tiruppathi C, Jaffe A, Xu N, Malik AB. Zhou MY, et al. J Clin Invest. 1998 Jun 1;101(11):2427-37. doi: 10.1172/JCI407. J Clin Invest. 1998. PMID: 9616214 Free PMC article.
-
Gene Therapy for Respiratory Diseases: Progress and a Changing Context.
Alton EWFW, Boyd AC, Davies JC, Gill DR, Griesenbach U, Harman TE, Hyde S, McLachlan G. Alton EWFW, et al. Hum Gene Ther. 2020 Sep;31(17-18):911-916. doi: 10.1089/hum.2020.142. Hum Gene Ther. 2020. PMID: 32746737 Free PMC article. No abstract available.
-
Gene therapy for lung inflammatory diseases: not so far away?
Sallenave JM, Porteous DJ, Haslett C. Sallenave JM, et al. Thorax. 1997 Aug;52(8):742-4. doi: 10.1136/thx.52.8.742. Thorax. 1997. PMID: 9337837 Free PMC article.
-
Brown TI, Collie DS, Shaw DJ, Rzechorzek NM, Sallenave JM. Brown TI, et al. PLoS One. 2014 Sep 12;9(9):e107590. doi: 10.1371/journal.pone.0107590. eCollection 2014. PLoS One. 2014. PMID: 25216250 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical